Russia Cancer Vaccine Enteromix Shows 100% Efficacy in Early Trials: Breakthrough or Bold Claim?
Russia Cancer Vaccine Enteromix has shown 100% efficacy in early trials against colorectal cancer. Could this breakthrough redefine global oncology, or are the claims overstated? A New Hope in Cancer Research Russia has unveiled Enteromix, a personalized mRNA-based cancer vaccine that early trials suggest may be 100% effective and safe in treating colorectal cancer. Developed … Read more